感染医学(英文)(Infectious Medicine)

感染医学(英文)(Infectious Medicine) 知网目次万方目次维普目次

  • 国级普刊
基本信息
  • 主管单位:

    教育部

  • 主办单位:

    清华大学

  • 国际刊号:

    2097-0684;EISSN 2772-431X

  • 国内刊号:

    10-1774/R

  • 学科分类:

    预防医学|卫生学

  • 字数:

    10000-30000

  • 有无基金:

    /有基金 100.0%

  • 周期:

    CN外文-季刊

  • 特殊属性:

    外文期刊

联系信息
  • 电话:

    010-83470377(官网电话)

  • 邮箱:

    infectmed@tup.tsinghua.edu.cn(官网邮箱)

  • 复合因子:

    0

  • 综合因子:

    0

  • 收录:

    知网目次,万方目次,维普目次

  • 级别:

    国级普刊

期刊简介

《感染医学(英文)(Infectious Medicine)》期刊已被查看:

更新频次

单位占比

一作占比

/有基金-100.0%

投稿指南

1、投稿方式:在线投稿。

2、官网网址:

https://www.sciopen.com/journal/2097-0684

https://www.sciencedirect.com/journal/infectious-medicine

3、投稿系统:https://www.editorialmanager.com/imj

4、官网邮箱:infectmed@tup.tsinghua.edu.cn

5、官网电话:010-83470377

6、出刊日期:季刊,逢季末月出版。

2024年5月7日星期二

《感染医学(英文)》期刊简介

【微信公众号“清华大学出版社教学服务平台(qhdxcbs_js)”信息】

期刊简介

Infectious Medicine《感染医学(英文)》是由教育部主管,清华大学主办,清华大学出版社与 Elseiver战略合作下出版的一本跨学科的开放获取(OA)英文期刊。

Infectious Medicine 刊载传染病预防和控制研究新成果,交流新发传染病监测与检验新技术,探讨临床病例与治疗效果,报道新发传染病和动物源性传染病的交叉研究,力争成为研究人类传染病与动物源性传染病的一体化One Health平台。可发表述评、原创研究、综述、短篇报道和致编辑信件等文章,主题涵盖范围包括:

Ø  感染性疾病监测、诊断、观察和治疗的临床研究;

Ø  传染病和医院感染的流行病学防治;

Ø  感染的发病机制、微生物学和免疫学;

Ø  传染病疫苗的研发;

Ø  传染病公共卫生政策和防疫措施。

学术分区

Ø  医院感染

Ø  病原资源保藏,卫生政策和法规

Ø  微生物学诊断、细菌/病毒检测

Ø  基因组学、蛋白质组学、二代测序、生物信息学

Ø  媒介传播疾病、兽医/人畜共患传染病

Ø  临床科学、传染病病理生物学和免疫学

Ø  传染病的微生物生态学、监测与预警

Ø  疫苗研制与评价、传染病防疫措施

Ø  免疫学与感染的交叉点

Ø  医学大数据与人工智能

Infectious Medicine 采用自由格式投稿模式,减轻作者负担,且 2022-2024年免收文章出版费(APC)。

Infectious Medicine 注重文章的科学性、严谨性和新颖性,致力于报道新发传染病,紧跟国际学术热点,对于新冠肺炎、猴痘、鹦鹉热等均进行了重点报道。

《感染医学(英文)》作者指南

【官网信息】

Guide for Authors

Introduction

Manuscripts that cover subjects well studied in the literature that do not make an obviously fresh point or those which primarily confirm previous findings but in a different geographical area, are likely to be rejected unless there are novel clinical implications or they cover a hot new topic (eg a new virus).

If you are unsure as to the suitability of your article for publication in the IMJ, please send the Editors in-Chief a copy of your Abstract by E-mail, to infectmed@tup.tsinghua.edu.cn. They will then advise you on whether or not your work would be appropriate for publication.

Article types

Articles of the following types are accepted by the Editors: Full length articles (2500 word limit), Short communications (1250 word limit), Correspondence (500 word limit), and Review articles (3000 word limit). Structured abstracts of up to 250 words are required for full length articles and short communications, and unstructured abstracts of up to 250 words are required for reviews. Please note that word limits exclude the abstract, references, acknowledgements, figure captions and tables. Please follow link for detailed information on requirements for all article types.

Submission checklist

You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

• E-mail address

• Full postal address

All necessary files have been uploaded:

Manuscript:

• Include keywords

• All figures (include relevant captions)

• All tables (including titles, description, footnotes)

• Ensure all figure and table citations in the text match the files provided

• Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable)

Supplemental files (where applicable)

Further considerations

• Manuscript has been 'spell checked' and 'grammar checked'

• All references mentioned in the Reference List are cited in the text, and vice versa

• Permission has been obtained for use of copyrighted material from other sources (including the Internet)

• A competing interests statement is provided, even if the authors have no competing interests to declare

• Journal policies detailed in this guide have been reviewed

• Referee suggestions and contact details provided, based on journal requirements

Ethics in publishing

Please see our information on Ethics in publishing.

Studies in humans and animals

If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.

Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.

Conflict of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. This summary statement will be ultimately published if the article is accepted. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.

Preprints

Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).

……

更多详情:

https://www.sciencedirect.com/journal/infectious-medicine/publish/guide-for-authors


中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。